New hope for kids with kidney disease: rituximab cuts relapse risk
Disease control
Completed
This study tested whether rituximab, a medication that targets certain immune cells, could help children with a challenging form of nephrotic syndrome (a kidney disease) that keeps coming back. 91 children were split into two groups: one received rituximab plus special nursing ca…
Phase: NA • Sponsor: Wuhan Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC